DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-12.82%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.55B
AUM Growth
-$433M
(-14%)
Cap. Flow
-$275M
Cap. Flow
% of AUM
-10.77%
Top 10 Holdings %
Top 10 Hldgs %
31.13%
Holding
150
New
29
Increased
31
Reduced
32
Closed
16
Top Buys
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$37.5M |
| 2 |
GSK
GSK
|
$34.8M |
| 3 |
Regenxbio
RGNX
|
$29.4M |
| 4 |
AET
Aetna Inc
AET
|
$29.1M |
| 5 |
AAC
AAC Holdings, Inc.
AAC
|
$28.9M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$82.8M |
| 2 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$38M |
| 3 |
Inogen
INGN
|
$26.8M |
| 4 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$24.9M |
| 5 |
Boston Scientific
BSX
|
$24.9M |
Sector Composition
| 1 | Healthcare | 69.73% |
| 2 | Financials | 4.83% |
| 3 | Technology | 0.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELGX
26
DELISTED
Endologix Inc
ELGX
| $28.8M | 1.11% |
234,711
-10,279
| -4% | -$1.26M |
|
|
SRRA
27
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $27.7M | 1.07% |
+33,710
| New | +$27.7M |
|
|
AKTX
28
Akari Therapeutics
AKTX
$21.4M
| $27.6M | 1.07% |
+57,535
| New | +$27.6M |
|
29
Zevra Therapeutics
ZVRA
$501M
| $27.5M | 1.06% |
88,781
+21,003
| +31% | +$6.51M |
|
|
SAGE
30
DELISTED
Sage Therapeutics
SAGE
| $27.5M | 1.06% |
649,064
+344,064
| +113% | +$14.6M |
|
|
TVTY
31
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $27.4M | 1.06% |
2,465,042
| – | – |
|
|
ATRS
32
DELISTED
Antares Pharma, Inc.
ATRS
| $26.3M | 1.02% |
15,451,124
-2,938,665
| -16% | -$5M |
|
|
RAD
33
DELISTED
Rite Aid Corporation
RAD
| $25.6M | 0.99% |
211,140
+116,640
| +123% | +$14.2M |
|
|
GHDX
34
DELISTED
Genomic Health, Inc.
GHDX
| $23.1M | 0.9% |
1,093,516
-89,484
| -8% | -$1.89M |
|
35
Xencor
XNCR
$594M
| $21.9M | 0.85% |
1,787,000
+376,000
| +27% | +$4.6M |
|
|
IMPR
36
DELISTED
IMPRIVATA, INC COM
IMPR
| $20.5M | 0.79% |
1,151,140
+192,988
| +20% | +$3.43M |
|
|
GI
37
DELISTED
EndoChoice Holdings, Inc.
GI
| $20.4M | 0.79% |
1,797,709
| – | – |
|
|
RLYP
38
DELISTED
RELYPSA INC COM
RLYP
| $20.4M | 0.79% |
1,101,000
+876,000
| +389% | +$16.2M |
|
|
MNK
39
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $20.3M | 0.79% |
+317,931
| New | +$20.3M |
|
40
Elevance Health
ELV
$72.4B
| $19.7M | 0.76% |
140,806
| – | – |
|
|
LOXO
41
DELISTED
Loxo Oncology, Inc
LOXO
| $19M | 0.74% |
1,088,225
-361,926
| -25% | -$6.33M |
|
42
Galapagos
GLPG
$2.06B
| $18M | 0.69% |
441,085
-201,523
| -31% | -$8.2M |
|
43
Larimar Therapeutics
LRMR
$337M
| $17.7M | 0.68% |
46,123
-37,845
| -45% | -$14.5M |
|
44
Protara Therapeutics
TARA
$125M
| $17.6M | 0.68% |
31,634
| – | – |
|
|
DBVT
45
DBV Technologies
DBVT
$249M
| $16.4M | 0.64% |
46,187
+30,161
| +188% | +$10.7M |
|
|
ELOS
46
DELISTED
Syneron Medical Ltd
ELOS
| $14.9M | 0.58% |
2,079,013
+105,068
| +5% | +$751K |
|
|
AERI
47
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $14.3M | 0.55% |
807,875
-1,403,769
| -63% | -$24.9M |
|
|
NSTG
48
DELISTED
NanoString Technologies, Inc.
NSTG
| $14.1M | 0.55% |
880,622
-352,074
| -29% | -$5.63M |
|
|
PTLA
49
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $14.1M | 0.54% |
329,837
| – | – |
|
50
Axogen
AXGN
$718M
| $13.9M | 0.54% |
3,381,439
-345,000
| -9% | -$1.42M |
|